⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1325067 | 1.00 | — | — | |
| SCHEMBL298356 | 1.00 | — | — | |
| SCHEMBL9421460 | 1.00 | — | — | |
| SCHEMBL11850707 | 1.00 | — | — | |
| SCHEMBL11275567 | 1.00 | — | — | |
| SCHEMBL3120297 | 1.00 | — | — | |
| SCHEMBL1195 | 1.00 | — | — | |
| SCHEMBL11120048 | 0.82 | — | — | |
| Lithium Ion SCHEMBL866810 | 0.82 | — | — | |
| SCHEMBL5147164 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658689-A2 | PHOSPHOMIMETIC MUTANTS, PHOSPHOSPECIFIC ANTIBODIES, AND USES THEREOF | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024163923-A2 | PHOSPHOMIMETIC MUTANTS, PHOSPHOSPECIFIC ANTIBODIES, AND USES THEREOF | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2024-08-08 | — | — | WO | disclosed |
| EP-3151671-A1 | METHODS AND COMPOSITIONS FOR TREATING NITRIC OXIDE DEFICIENCY DISORDERS AND RELATED CONDITIONS | Sulfagenix, Inc. (US) | 2017-04-12 | — | — | EP | disclosed |
| US-20170087180-A1 | METHODS AND COMPOSITIONS FOR TREATING NITRIC OXIDE DEFICIENCY DISORDERS AND RELATED CONDITIONS | SULFAGENIX, INC. | 2017-03-30 | — | — | US | disclosed |
| CN-105228633-A | For the compositions of the whole body therapeutic of the pathological state by oxidative stress and/or the unbalance generation of oxidoreduction | NUEVAS ALTERNATIVAS NATURALES S A P I DE C V | 2016-01-06 | — | — | CN | disclosed |
| WO-2015187649-A1 | METHODS AND COMPOSITIONS FOR TREATING NITRIC OXIDE DEFICIENCY DISORDERS AND RELATED CONDITIONS | SULFAGENIX, INC. (US) | 2015-12-10 | — | — | WO | disclosed |
| EP-2949332-A2 | COMPOSITIONS FOR THE SYSTEMIC TREATMENT OF PATHOLOGICAL CONDITIONS RESULTING FROM OXIDATIVE STRESS AND/OR REDOX IMBALANCE | Nuevas Alternativas Naturales Thermafat, S.A.P.I. de C.V. (MX) | 2015-12-02 | — | — | EP | disclosed |
| US-20150174160-A1 | METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES | PRAVDA JAY (US) | 2015-06-25 | — | — | US | disclosed |
| EP-2866565-A2 | METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES | Pravda, Jay (US) | 2015-05-06 | — | — | EP | disclosed |
| CN-104582490-A | Methods of treating, diagnosing and/or monitoring the progression of oxygen-related diseases | PRAVDA JAY | 2015-04-29 | — | — | CN | disclosed |
| WO-2014008273-A2 | METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES | PRAVDA JAY (US) | 2014-01-09 | — | — | WO | disclosed |
| US-20130136725-A1 | COMPOSITIONS FOR SYSTEMIC TREATMENT OF PATHOLOGICAL CONDITIONS RESULTING FROM OXIDATIVE STRESS AND/OR REDOX IMBALANCE | NUEVAS ALTERNATIVAS NATURALES THERMAFAT, S.A.P.I. DE C.V. (MX) | 2013-05-30 | — | — | US | disclosed |
| US-8389005-B2 | Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance | NUEVAS ALTERNATIVAS NATURALES THERMAFAT, S.A.P.I. DE C.V. (MX) | 2013-03-05 | — | — | US | disclosed |
| US-8361514-B2 | Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance | Nuevas Alternatives Naturales Thermafat, S.A.P.I. de C.V. (MX) | 2013-01-29 | — | — | US | disclosed |
| US-20090304819-A1 | Systemic Treatment of Pathological Conditions Resulting from Oxidative Stress and/or Redox Imbalance | SULFAGENIX, INC. | 2009-12-10 | — | — | US | disclosed |
| US-20090181081-A1 | Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance | SULFAGENIX, INC. | 2009-07-16 | — | — | US | disclosed |
| US-20030235571-A1 | Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance | GOJON-ROMANILLOS GABRIEL (MX) | 2003-12-25 | — | — | US | disclosed |
| US-3976769-A | INSECTICIDE | AIRWICK INDUSTRIES, INC. (US) | 1976-08-24 | — | — | US | disclosed |